The untold story of life with Prader–Willi syndrome, according to the siblings who live it

New research from the University of East Anglia (UK) reveals the hidden struggles experienced by the brothers and sisters of ...

Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...
Healio

Withdrawal from oral therapy tied to worsened hyperphagia in Prader-Willi syndrome

Children and adults with Prader-Willi syndrome who previously received once-daily diazoxide choline extended-release tablets ...
Earth.com

Siblings of children with rare disorders face hidden emotional strain

Siblings of children with Prader-Willi syndrome feel stressed, lonely, and need better support says new research.
Verywell Health on MSN

Prader-Willi syndrome symptoms and treatment

Medically reviewed by Kashif J. Piracha, MD Key Takeaways Children with Prader-Willi syndrome often never feel full and may ...

Assessing Soleno Therapeutics (SLNO) Valuation After JCEM VYKAT XR Data And FDA Approval

Why the latest JCEM publication matters for Soleno Therapeutics (SLNO) Soleno Therapeutics (SLNO) is back in focus after a ...
The American Journal of Managed Care

Urinalysis May Be Effective Screening Tool for Kidney Disease in Prader-Willi Syndrome

Patients with Prader-Willi syndrome showed early signs of microvascular disease upon screening. In a study using urinalysis screening to detect microvascular disease, 1 in 5 adults with Prader-Willi ...
inforum

Appetite for life: 4-year-old Fargo girl lives with rare genetic disorder, Prader-Willi syndrome

Juliana Steffan's mother, April Steffan, created a YouTube video about Prader-Willi syndrome, a rare genetic disorder that causes a chronic feeling of hunger, among other physical, mental and ...
Seeking Alpha

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

-- Company will host a webcast at 10am ET on November 6, 2025, to discuss its Phase 2a study to assess efficacy, safety and tolerability of BMB-101 (NOVA Study) for the treatment of patients with ...